Delivery Order SPE2DB22D2206-SPE2DB25FKC80
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,365.40 to AmerisourceBergen Drug Corp for Fentanyl 100 mcg/2 mL vials on July 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.68 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 micrograms per 2 milliliter vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,258.56 for Fentanyl 100 MCG/2 ML vials on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 MCG/2 ML Vial 2ML, valued at $1,667.43. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Fentanyl 100 mcg/2 mL vials with a ceiling value of $2,448.68. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement for federal medical supply needs,...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,889.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4565795691 - FENTANYL 250 MCG/5 ML VIAL 5ML, a critical pharmaceutical product, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,689 firm-fixed-price delivery order covers the supply of 4,563,303,395 units of the drug Fentanyl 100 mcg/2 ml vial. The award has an ultimate completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This delivery order, awarded on August 19, 2025, to AmerisourceBergen Drug Corp for $1,663.26, procures 1,000 microgram/20 milliliter vials of Fentanyl. The contract is a firm fixed price delivery order under the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of August 20, 2025. The award is unset-aside and represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,168.51, is for the supply of 4563927584 Fentanyl 100 MCG/2 ML vials. The contract is a Firm Fixed Price arrangement and has a completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,201.32 firm fixed-price delivery order is for the supply of 4,566,243,239 units of 100 mcg/2 mL fentanyl vials. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC80Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,311.00 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 micrograms per 2 milliliter vials. This firm fixed-price contract, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order falls within the scope of the company's comprehensive IDC valued at $999,999,999.00 through December 2026, which enables the supply of a broad range of pharmaceutical products and medical supplies to support Defense Health Agency and other federal healthcare programs worldwide. This transaction exemplifies the vendor's role in supplying essential pharmaceutical commodities to meet federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/25/25 |